Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07819643) titled 'RESCUE: PCSK9 Inhibitors for Carotid Vulnerable Plaque Remodeling' on Sept. 6.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Keqiang Zhao
Condition:
Atherosclerosis Cerebral
Carotid Plaque
Vulnerable Plaque
Carotid Stenosis
Intervention:
Drug: Intervention 1
Drug: Intervention 3
Drug: Intervention 2
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: January 1, 2027
Target Sample Size: 120
To know more, visit https://clinicaltrials.gov/st...